[Endothelial dysfunction, inflammation and statins: new evidences]

Rev Esp Cardiol. 2004 Oct;57(10):903-5.
[Article in Spanish]
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Animals
  • Anticholesteremic Agents / pharmacology*
  • Anticholesteremic Agents / therapeutic use
  • Atorvastatin
  • C-Reactive Protein / analysis
  • Coronary Circulation / drug effects*
  • Endothelium, Vascular / drug effects*
  • Endothelium, Vascular / physiopathology
  • Follow-Up Studies
  • Heptanoic Acids / administration & dosage
  • Heptanoic Acids / pharmacology
  • Heptanoic Acids / therapeutic use
  • Humans
  • Hypercholesterolemia / drug therapy
  • Inflammation / drug therapy*
  • Interleukin-6 / blood
  • Pravastatin / administration & dosage
  • Pravastatin / pharmacology
  • Pravastatin / therapeutic use
  • Pyrroles / administration & dosage
  • Pyrroles / pharmacology
  • Pyrroles / therapeutic use
  • Rabbits
  • Time Factors

Substances

  • Anticholesteremic Agents
  • Heptanoic Acids
  • Interleukin-6
  • Pyrroles
  • C-Reactive Protein
  • Atorvastatin
  • Pravastatin